QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

HIMS

QT51Hims & Hers Health, Inc.
NYSE·Healthcare·Medical - Equipment & Services·USA
Latest market price
35.47
+3.58+11.23%
OverviewShort InterestFilings
HIMSQT51Hims & Hers Health, Inc.·NYSE
OverviewShort InterestFilings
35.47+11.23%
TA
Loading chart...
Screen all →
NVST+4.22%$25.91CON+0.63%$28.56BBNX+5.23%$13.88
Snapshot
Index-P/E-EPS (ttm)-0.09Insider Own2.92%Shs Outstand231.46MPerf Week
22.86%
Market Cap7.38BForward P/E75.30EPS next Y0.47Insider Trans0.99%Shs Float-Perf Month58.07%
Enterprise Value8.17BPEG5.27EPS next Q-0.08Inst Own-Short Float-Perf Quarter46.81%
Income-13070257.00P/S3.06EPS this Y-2.65%Inst Trans-Short Ratio-Perf Half Y-3.77%
Sales2.37BP/B16.66EPS next Y609.93%ROA-0.58%Short Interest-Perf YTD9.24%
Book/sh1.93P/C26.20EPS next 5Y-ROE-2.48%52W High70.43 -49.64%Perf Year-40.12%
Cash/sh3.24P/FCF95.75EPS past 3/5Y-ROIC0.66%52W Low13.74 158.15%Perf 3Y-
Dividend Est.-EV/EBITDA271.85Sales past 3/5Y64.55% 73.58%Gross Margin67.64%Volatility4.56% 5.02%Perf 5Y-
Dividend TTM-EV/Sales3.45EPS Y/Y TTM-118.87%Oper. Margin1.32%ATR (14)2.35Perf 10Y-
Dividend Ex-Date-Quick Ratio1.55Sales Y/Y TTM60.46%Profit Margin-0.56%RSI (14)71.08Recom2.70
Dividend Gr. 3/5Y-Current Ratio1.69EPS Q/Q-300.00%SMA2028.06%Beta2.54Target Price28.08
Payout0.00%Debt/Eq2.54Sales Q/Q3.75%SMA5033.13%Rel Volume1.19Prev Close31.89
Employees1,637LT Debt/Eq2.06EarningsAug 10SMA2006.33%Avg Volume26.72MPrice35.47
IPO DateSep 13, 2019Option/ShortYes / YesEPS/Sales Surpr.-1676.67% -1.46%Net Debt/EBITDA30.27Volume31,750,287Change11.23%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-17-26ReiteratedBarclaysOverweight$29 → $39
Jun-02-26ReiteratedLeerink PartnersMarket Perform$18 → $25
May-26-26ReiteratedUBS$23 → $25
May-22-26ReiteratedUBS$18 → $23
May-12-26ReiteratedJefferiesHold$26 → $25
May-12-26ReiteratedUBS$30 → $35
May-12-26ReiteratedCanaccord GenuityBuy$30 → $32
May-05-26ReiteratedDeutsche BankHold$28 → $25
Mar-10-26UpgradeCitigroupSell → Neutral
Mar-10-26UpgradeB of A SecuritiesUnderperform → Neutral
Latest News
Jun-18-26
Jun-18-2606:14PM
Living Longer Is Big Business. These Stocks Will Benefit.Yahoo
05:59PM
Hims & Hers Rallies With a July FDA Decision LoomingYahoo
02:17PM
Hims & Hers Stock Jumps After Barclays Raises Price TargetBenzinga
06:33AM
Hims & Hers: The Bull Case Remains StrongSeekingAlpha
Jun-17-26
Jun-17-2610:36PM
Hims & Hers Health: Legal Risks Resolved With New International Growth Driver - Maintain BuySeekingAlpha
09:45PM
Hims & Hers Health, Inc. (HIMS) Ascends While Market Falls: Some Facts to NoteYahoo
08:46PM
HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo PartnershipYahoo
12:04PM
HIMS Stock Breaks Above $30 Ahead Of Upcoming FDA Peptide Review: Analysts Eye Next Growth CatalystYahoo
Jun-16-26
Jun-16-2608:19PM
Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides MarketYahoo
06:08PM
Hims & Hers Enters A New PhaseSeekingAlpha
12:37PM
Hims & Hers Stock Is Climbing Tuesday: What Investors Need To KnowBenzinga
09:00AM
3 Market-Beating Stocks with Exciting PotentialYahoo
05:53AM
HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030Yahoo
01:43AM
Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum BuildsYahoo
Jun-15-26
Jun-15-2611:17PM
Why Hims & Hers Health (HIMS) Is Up 11.0% After GLP-1 Weight Loss Pivot And Telehealth DealYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue2,3702,3481,477
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A767614303
Gross Profit1,6021,7331,173
Selling, General and Administrative Excl. Other1,2441,192847
Research and Development16714979
Other Operating Expense160287185
Operating Income3210662
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)70-18-10
Net Income Before Taxes-3912472
Income Taxes-25-4-54
Consolidated Net Income-12128126
Net Income From Continuing Operations-12128126
Net Income-12128126
EPS (Recurring)-0.050.570.58
EPS (Basic, Before Extraordinaries)-0.050.570.58
EPS (Diluted)-0.090.510.53
EBITDA2917889
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio—63.67—
Price To Sales Ratio3.413.11—
Gross Margin67.5973.8179.42
Operating Margin1.354.514.20
Net Margin-0.515.458.53
Shares Outstanding228225216
Market Capitalization8,0877,306—
Operating Lease Expense
———
Insider Trading Volume
$39.48$36.95$34.42$31.90$29.37● Close Price0.00M11.46M22.92M34.38M45.84MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Becklund IrenePAOJun 17 '26Sale31.504,490141,4356,790Jun 17 12:00 AM
Chi MichaelChief Operating OfficerJun 17 '26Sale31.5014,027441,851432,124Jun 17 12:00 AM
Elshenawy MohamedCTOJun 17 '26Sale31.5030,040946,260101,023Jun 17 12:00 AM
Becklund IrenePAOJun 16 '26Sale30.257,573229,08311,280Jun 17 12:00 AM
Carroll Patrick HarrisonChief Medical OfficerJun 15 '26Option Exercise0.0052,7220213,897Jun 17 12:00 AM
Okupe OluyemiChief Financial OfficerJun 15 '26Option Exercise0.00143,2320335,683Jun 17 12:00 AM
Autor Deborah M.Chief Policy OfficerJun 15 '26Option Exercise0.0065,8380460,873Jun 17 12:00 AM
Chi MichaelChief Operating OfficerJun 15 '26Option Exercise0.00172,5280493,850Jun 17 12:00 AM
Becklund IrenePAOJun 15 '26Option Exercise0.0031,942058,197Jun 17 12:00 AM
Boughton SoleilChief Legal OfficerJun 15 '26Option Exercise0.0084,5220341,629Jun 17 12:00 AM
Dudum AndrewChief Executive OfficerJun 15 '26Option Exercise0.00309,98201,042,675Jun 17 12:00 AM
Elshenawy MohamedCTOJun 15 '26Option Exercise0.00565,1940777,255Jun 17 12:00 AM
WELLS DAVID BDirectorJun 15 '26Option Exercise0.001,9140229,030Jun 15 12:00 AM
Payne Christopher DDirectorJun 15 '26Option Exercise0.0021,374034,318Jun 15 12:00 AM
Manuel AnjaDirectorJun 15 '26Option Exercise0.0020,080038,671Jun 15 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR